| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
January 22, 2025 records indicate that Representative Thomas Kean filed a purchase of Abbott Laboratories (NYSE:ABT), valued between $1,001 and $15,000. According to the January filing, the transaction occurred on January 22, 2025.
Currently, Abbott Laboratories shares are trading up 2.78% at $121.05.
In the past three years, Thomas Kean made 68 stock trades totaling more than $320 thousand. The largest trades involved stocks like Aon and Johnson & Johnson. Their most notable trades made recently include key transactions:
Here's a summary of Thomas Kean's recent trades:
| Company | Ticker | Stock Type | Amount | Transaction Type | Transaction Date |
|---|---|---|---|---|---|
| Canadian Pacific Kansas | CP | STOCK | $1,001 - $15,000 | P | 2024-12-27 |
| Pernod Ricard | PRNDY | STOCK | $1,001 - $15,000 | S | 2024-12-27 |
| Alphabet | GOOG | STOCK | $1,001 - $15,000 | S | 2024-12-19 |
| Abbott Laboratories | ABT | STOCK | $1,001 - $15,000 | P | 2024-12-16 |
| Franklin Resources | BEN | STOCK | $1,001 - $15,000 | S (Partial) | 2024-12-16 |
To keep an eye on Thomas Kean's trades and other government stock activity, check out our real-time tracking tool!
A congressional transaction is when any representative or senator either buys or sells an individual stock.
Anyone working in Congress must file a Periodic Transaction Report to inform the public of their recent transaction within 30 days of being notified of the transaction and within 45 days of the transaction date.
In April 2012, Former President Barack Obama signed the STOCK Act into law. The act prohibits members of Congress from using private information given to them by their position for personal gain such as buying or selling a stock. The act also expanded disclosure requirements for members of Congress by requiring them to file a monthly disclosure.
Congressional transactions shouldn't be the primary reason for an investing decision, but they can be an important factor for an investor to consider.
When a senator or representative makes a new purchase, it could be an indication they expect the stock to rise.
A sale, on the other hand, can be made for a variety of reasons, and may not necessarily mean the seller thinks the stock will go down.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
